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Abstract
Background: Recurrent aphthous stomatitis (RAS) is the most common form of oral ulcerative disease, whose
cause is still unknown. Researchers have found the association of many factors with the occurrence of RAS, and
proposed oral bacterial infection could be a cause for this disease.
Methods: To investigate whether the occurrence of RAS is associated with oral bacterial infection, we performed
high throughput sequencing analysis of bacterial samples collected from the normal oral mucosa and aphthous
ulcers of 24 patients.
Results: Firmicutes, Proteobacteria and Bacteriodetes were the most abundant phyla in the microbiomes analysed.
The alpha diversities of the oral mucosa and aphthous ulcer microbiomes were similar, suggesting a similar richness
and diversity. The NMDS analysis showed the oral mucosa and aphthous ulcer microbiomes are significantly
different. This suggestion is further supported by Anosim, MRPP, and Adonis analyses. More detailed comparison of
the two groups of microbiomes suggested that the occurrence of RAS is significantly associated with the increase
of Escherichia coli and Alloprevotella, as well as the decrease of Streptococcus.
Conclusions: Considering E. coli is a very common intestinal bacterium, we propose that E. coli colonization could
be a cause for RAS, and controlling E. coli colonization could help curing RAS.
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Background
Recurrent aphthous stomatitis (RAS) is the most com-
mon form of oral ulcerative disease that affects as much
as 5–20% of the population. It is characterized by shal-
low round ulcers that afflicts pain on the patients [1].
These lesions are benign and self-limiting, but are usu-
ally chronic and frequently recur [2], leading to difficul-
ties in oral functions [3].
The etiology of RAS is still unclear, although associ-
ation between RAS and a number of factors have been
reported. These factors include local trauma [4], saliva
composition changes [5], a series of systematic diseases
such as HIV infection [6] and Crohn’s disease [7], gen-
etic factors [8], food allergy [9], immunological factors
[10], stress [11], nutritional deficiency [12], and micro-
bial agents [13]. The lack of clear understanding of the
etiology of RAS hinders the efficient treatment of this
disease.
The role of several bacterial species in RAS has been
implicated in previous investigations by culture-
dependent techniques. Helicobacter pylori has been
found on RAS lesions [14], and association between H.
pylori and RAS has been suggested [13], although this
association has been controversial [15]. Several
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: wangmingyu@sdu.edu.cn; haixu@sdu.edu.cn
1State Key Laboratory of Microbial Technology, Qilu Hospital, Shandong
University, Qingdao, Shandong, China
Full list of author information is available at the end of the article
Yang et al. BMC Oral Health          (2020) 20:128 
https://doi.org/10.1186/s12903-020-01115-5
Streptococcus species have been suspected to be involved
in the development of RAS [16], and this involvement
was suggested to be the result of autoimmune reaction
of streptococcal heat-shock proteins [17]. Despite these
investigations, no definitive connection between micro-
bial infection and RAS has been demonstrated.
The emergence of high-throughput sequencing and
various other high-throughput microbial techniques
allowed in-depth culture-independent analysis of micro-
bial colonization, and has been proven successful in de-
tecting key pathogens for various diseases [18]. To date,
several studies have been performed in attempt to
understand the bacterial community composition in
RAS-affected patients. Marchini et al. compared the
microbiomes of 10 healthy and 10 RAS-affected subjects
using 16S rDNA library-dependent cloning techniques,
and found different microbiome structures [19]. Bankvall
et al. compared the microbiomes of 60 healthy and 60
RAS-affected patients using Terminal-Restriction Frag-
ment Length Polymorphism (T-RFLP) of 16S rDNA
amplicons, and found differences in T-RFLP patterns,
but were unable to pinpoint the key pathogens involved
in RAS [20]. Seoudi et al. compared the saliva micro-
biomes of 26 healthy subjects and 8 RAS-affected pa-
tients using human oral microbe identification
microarray analysis, and found decreased levels of
Rothia, Neisseria, and Veillonella in RAS-affected pa-
tients [21]. Kim et al. compared the microbiomes of oral
mucosa (n = 18) and saliva (n = 7) of RAS-affected pa-
tients with healthy subjects (n = 18) using 454 pyrose-
quencing of 16S rDNA, and found the association of the
decrease of Streptococcus salivarius and the increase of
Acinetobacter johnsonii with RAS risk [22]. Hijazi et al.
performed 454 pyrosequencing of 16S rDNA from 18
RAS-affected patients and 17 healthy subjects, and found
higher levels of Bacteroidales, Porphyromonadaceae and
Veillonellaceae, along with decreased Streptococcaceae
in association with RAS [23]. These investigations have a
small sample size and cannot identify a significant differ-
ence (clustering) in the overall bacterial community be-
tween healthy and disease-affected samples, and have a
lower sequencing depth (read numbers) and therefore
could lead to missing information. Therefore, a more de-
tailed comparison of microbiota between healthy and
RAS-affected subjects is warranted.
In this work, we performed an in-depth analysis
and comparison of the microbiomes between healthy
mucosa and RAS lesions from 24 RAS-affected pa-
tients by high throughput Illumina sequencing of 16S
rDNA, with an average sequence depth of 68,633
reads per sample. Suggestions on the association of
specific bacteria with RAS are made that require fur-
ther mechanistic investigations for the confirmation
of etiology.
Methods
Sample collection and DNA extraction
Bacterial samples were taken from the surface of normal
oral mucosa and aphthous ulcers from 24 RAS patients
in the Second Hospital of Shandong University and
Stomatological Hospital of Shandong University using
sterile cotton in 2018. RAS patients that did not take
antibiotics at least 3 months prior to the sampling were
recruited as participants of the experiments (Add-
itional file 1). Systematic diseases and other medication
were not considered. Approximately 50% of the partici-
pants were male (male: female = 13: 11). Most of the par-
ticipants are mid-aged or older (20–30: 3/24, 30–40: 7/
24, 40–50: 6/24; above 50: 8/24). RAS was diagnosed by
the authors following criteria previously documented in
literature [1]. Most of the lesions are single episodes (19/
24, one ulcer per person), and are minor RAS (20/24, re-
mainders being major RAS). The number of patients
was arrived at based on requirement of the high-
throughput microbiome sequencing technique that gen-
erally requires at least 20 samples for clear conclusions.
The site of sample collection for healthy mucosa is on
the opposite side of the ulcers to avoid cross-
contamination. The heads of the cotton swabs were cut
off with sterile scissors, soaked in 0.9% NaCl, and vor-
texed for 5 min. The total DNA was subsequently ex-
tracted with Plant Genomic DNA Kit (Tiangen Biotech
(Beijing) Co., Ltd., Beijing China). The DNA content was
determined prior to high throughput sequencing.
16S rDNA high throughput sequencing and data analysis
The V4-V5 region of 16S rDNA was PCR amplified from
extracted DNA samples for the determination of bacter-
ial community composition by high throughput sequen-
cing using Illumina HiSeq2500 PE250 (Illumina Inc., San
Diego, CA). Raw tags were obtained using FLASH
V1.2.7, and processed using Qiime V1.9.1 to obtain clean
tags. Chimera were removed using the UCHIME algo-
rithm and Gold database to obtain effective tags. This
was performed to obtain effective tags and to exclude
potential bias introduced during read generation. The ef-
fective tags were grouped into Operational Taxonomic
Units (OTUs) with a 97% sequence identity cutoff using
Uparse V7.1.1001. Annotation of the taxonomy of each
OTU was performed using the Mothur method and the
SILVA database. The levels of each OTU were normal-
ized for further analysis of alpha and beta diversity.
The alpha diversity indexes were calculated using
Qiime V1.9.1. Rarefaction curves were drawn using R
V2.15.3. Weighted Unifrac distances were calculated
using Qiime V1.9.1. Anosim, MRPP and Adonis analyses
were performed using the vegan package of R software.
NDMS analysis was performed using the vegan package
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of the R software. LEfSe analysis was performed using
the LEfSe software with a default LDA score cutoff of 4.
Statistics
Two-tailed t-tests were performed for the comparison of
bacterial community composition between oral mucosa
microbiomes and aphthous ulcer microbiomes.
Ethics
The experiments in this study were conducted in ac-
cordance with the Declaration of Helsinki, and were ap-
proved by the Scientific Ethics Committee of Qilu
Hospital, Shandong University. Consent to participate
was obtained from all subjects verbally as samples were
taken from outpatients in scenarios where patients’ time
is limited for the purpose of preparing necessary written
documents. This procedure was approved by the Scien-
tific Ethics Committee of Qilu Hospital.
Results
The bacterial community compositions of oral mucosa
and aphthous ulcers
In order to understand the bacterial community compo-
sitions of oral bacterial and aphthous ulcers, we col-
lected bacterial samples from normal oral mucosa and
aphthous ulcers from 24 patients using cotton swabs.
Total DNA was extracted from these samples, from
which 16S rDNA was amplified and sequenced by high
throughput sequencing. An average sequence depth of
68,633 reads per sample was obtained. These reads were
grouped into Operational Taxonomic Units (OTUs) with
97% sequence identity as cutoff. An average of 570
OTUs/sample were found.
The majority of oral bacteria found in this study be-
long to three phyla: Firmicutes, Proteobacteria and Bac-
teroidetes (Fig. 1a). The 10 most abundant genera are
Streptococcus, Prevotella, Haemophilus, Neisseria, Acti-
nobacillus, Alloprevotella, Veillonella, Escherichia-Shi-
gella, Candidatus Competibacter, and Porphyromonas
(Fig. 1b). It is worth noting that the top 3 phyla repre-
sent 99.41% of all bacteria, and the top 10 genera repre-
sent 81.90% of all bacteria.
Alpha diversity of oral and aphthous ulcerative
microbiomes
The alpha diversity indexes that indicate the community
richness and diversity of bacteria in oral mucosa and
aphthous ulcers were calculated. The observed species
index explains the number of species identified in a bac-
terial community. Shannon and Simpson indexes are in-
dicators for the diversities of bacterial communities,
while the Chao1 and Abundance-based Coverage
Fig. 1 The bacterial community composition of oral mucosa and aphthous ulcers. a bacterial community composition on the phylum level; b
bacterial community composition on the genus level. Sx.0 indicates the oral mucosa of subject x; Sx.1 indicates the aphthous ulcers of subject x
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Estimation (ACE) estimators are indicators for the rich-
ness of bacterial communities. The rarefaction curves of
the two groups of microbiomes suggest similar richness
and diversity (Fig. 2). This observation is echoed by the
finding that the Shannon indexes, Simpson indexes,
Chao1 estimators, ACE estimators were similar between
the two groups of microbiomes (Table 1). More detailed
comparison of these indexes between oral and aphthous
ulcerative microbiomes of the same individual further
confirmed this finding: Although differences can be
found between each pair of compared microbiomes for
several subjects (such as Shannon index for individual
S15 and Chao1 estimator for individual S10), the indexes
are close for the same subject for the majority of sub-
jects investigated. These findings suggest that the alpha
diversity of microbiomes in oral mucosa and aphthous
ulcers are similar.
Analysis of the bacterial community compositions of oral
mucosa and aphthous ulcers
The Non-Metric Multi-Dimensional Scaling (NMDS)
analysis was performed on the bacterial community
compositions of oral mucosa and aphthous ulcers
(Fig. 3). The oral mucosa and aphthous ulcer groups are
clearly distinguished, suggesting a significant difference
between the bacterial community compositions of the
two types of microbiota. This is further confirmed by
Anosim (p = 0.009), MRPP (p = 0.004), and Adonis (p =
0.004) analyses, all suggesting the differences between
the oral mucosa and aphthous ulcer groups are signifi-
cantly bigger than within each group. These results sug-
gest a clear and significant difference between the
bacterial community compositions of oral mucosa and
aphthous ulcers, although the richness and diversity in-
dexes of their bacterial communities are largely similar.
Significantly different bacterial groups between the
microbiomes of normal oral mucosa and aphthous ulcers
The LEfSe (LDA Effect Size) analysis searches for statis-
tically significant difference in metagenomics. This ana-
lysis was performed between the oral mucosa
microbiomes and the aphthous ulcer microbiomes
(Fig. 4). Significantly more represented in normal mu-
cosa samples are Firmicutes on the phylum level, Bacilli
on the class level, Lactobacillales on the order level,
Streptococcaceae on the family level, and Streptococcus
on the genus level (Fig. 4a). Significantly more repre-
sented in aphthous ulcer samples are Enterobacteriales
on the order level, Enterobacteriaceae on the family
level, Escherichia-Shigella and Alloprevotella on the
genus level, and Escherichia coli on the species level (Fig.
4b). From the Cladogram analysis, it can be seen that
Streptococcus is significantly enriched of the oral mucosa
microbiome, while Streptococcus and Alloprevotella are
significantly enriched in the aphthous ulcer microbiome
(Fig. 4b).
Statistical comparison between taxonomic abundances
in oral mucosa and aphthous ulcer microbiomes con-
firmed the roles of Streptococcus (p = 0.0077, mucosa
group 14.27–24.11% and aphthous ulcer group 7.88–
13.93% at 95% Cl), E. coli (p = 0.0031, mucosa group
1.60–4.40% and aphthous ulcer group 7.93–21.99% at
95% Cl) and Alloprevotella (p = 0.0427, mucosa group
4.05–7.17% and aphthous ulcer group 6.24–12.89% at
95% Cl) (Additional file 2). Other significantly enriched
taxa among the ten most abundant taxa at each
taxonomic level include: 1) Enriched in oral mucosa
microbiomes: Actinobacteria (p = 0.014, mucosa group
1.71–3.35% and aphthous ulcer group 0.84–1.75% at
95% Cl) at class level and Bacillales (p = 0.042, mucosa
group 1.72–3.37% and aphthous ulcer group 1.06–2.00%
at 95% Cl) at order level; 2) Enriched in aphthous ulcer
microbiomes: Porphyromonadaceae (p = 0.046, mucosa
group 1.35–1.74% and aphthous ulcer group 1.66–4.35%
at 95% Cl) at family level and Porphyromonas (p = 0.029,
mucosa group 1.28–1.66% and aphthous ulcer group
1.56–4.25% at 95% Cl) at genus level.
Discussion
Understanding the etiology of RAS is a big step forward
in finding effective cures for this common disease, and it
has been suspected that microbial infection contributes
to RAS [13, 16]. Recent progress in high throughput se-
quencing techniques enables metagenomic approaches
in understanding the microbiomes of biological samples,
therefore allows us to pinpoint the specific pathogen re-
sponsible for diseases by comparing the microbiomes of
pathological and normal tissues. Therefore, we exploited
high-throughput sequencing technologies in this work in
attempt to find specific association of bacterial
Fig. 2 The Rarefaction curve of normal mucosa and aphthous ulcer
microbiomes. Error bar indicates standard deviation (n = 24)
Yang et al. BMC Oral Health          (2020) 20:128 Page 4 of 8
community compositions with aphthous ulcers, which
further leads to proposals of the etiology of RAS.
In this work, we found that the increase of E. coli and
Alloprevotella, as well as the decrease of Streptococcus in
bacterial communities is significantly associated with
aphthous ulcers. The decrease of Streptococcus in aph-
thous ulcers is in agreement with previous findings [22,
23]. However, the increase of E. coli in aphthous ulcers
is a new and particularly intriguing finding. E. coli is one
of the most common bacteria in the human microbiome,
particularly intestinal microbiome [24]. Inoculation of E.
coli to oral mucosa is easy and common via the fecal-
oral pathway. Considering 40% of the human population
suffers from RAS, the cause of this disease has to be a
common factor. This common occurrence is in coinci-
dence with E. coli colonization which is also a very com-
mon phenomenon. Therefore, the significant association
of aphthous ulcers with E. coli abundance leads to the
proposal that E. coli colonization could be the cause of
RAS. Previous investigations suggested that Helicobacter
pylori could be the cause of RAS, but results from this
work do not suggest a significant correlation between
aphthous ulcers and H. pylori (p = 0.185). Therefore, we
doubt that H. pylori has a direct role in the formation of
aphthous ulcers, in agreement with the previous sugges-
tion that H. pylori does not play a role in RAS [15].
A number of previous studies investigated the micro-
biota of RAS [18–23]. These investigations are mostly
qualitative rather than quantitative, and cannot lead to
the identification of significantly enriched groups in the
bacterial community of aphthous ulcers. Three previous
studies quantified the microbial abundance of bacteria in
aphthous ulcers using microarray or pyrosequencing ap-
proaches [21–23]. These investigations either compared
the oral bacterial community composition of healthy
subject and patients and therefore suffered from back-
ground noise caused by differences between individuals
[22], involved saliva microbiome which could naturally
have different bacterial community composition with the
mucosa as saliva is a natural disinfectant [21, 22], or has
a relatively small sample size (n = 8 or 12) [21, 23]. In
particular, the two investigations with pyrosequencing
only had respectively 3000 and 9500 tags/sample [22,
23], which could lead to loss of information due to lower
sequencing depth and smaller sample volume. The
methods used in this work ruled out differences between
individuals by comparing the normal oral mucosa and
aphthous ulcers of the same individual, had a larger
sample volume (n = 24), and had a better sequencing
depth (> 68, 000 tags/sample). Therefore, we are able to
more effectively detect bacterial groups specific to aph-
thous ulcers in this work. It needs to be noted that sam-
ples were taken from only RAS patients intentionally
without collecting samples from healthy individuals as
controls, because it was decided that individual diversity
may contribute significantly towards differences in bac-
terial community leading to difficulties in finding bac-
teria that are associated with RAS. Including healthy
individuals will only complicate the study rather than
help it. Also, not having healthy controls does not
weaken the findings of this work as this work aims to
find RAS-associated, localized, ulcerative mucosa-
bearing microbes, and a proper control is the healthy
mucosa of the same individual. A large number of taxa
were found differently represented in oral mucosa and
aphthous ulcers (Additional file 2). With more stringent
statistical analysis like LEfSe, we are capable of identify-
ing E. coli and Alloprevotella as the bacterial groups spe-
cific to aphthous ulcers, which was never observed
before. We also confirmed previous findings that the re-
duction of Streptococcus (Streptococcaceae) and Rothia
is associated with aphthous ulcers [22, 23], while the in-
crease of Porphyromonadaceae is associated with aph-
thous ulcers [23]. Previous reports on the positive
association of Acinetobacter and Bacteroidales with aph-
thous ulcers, as well as the negative association of Neis-
seria with aphthous ulcers were not confirmed by our
Table 1 Alpha diversity indexes
Experimental group Observed species Shannon index Simpson index Chao1 estimator ACE estimator
Normal mucosa 198 3.68 0.836 219.404 222.88
Aphthous ulcers 203 3.681 0.843 234.721 234.363
Fig. 3 NMDS analysis of investigated bacterial communities. The red
oval covers the majority of normal mucosa samples. The green oval
covers the majority of aphthous ulcers
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results [21–23]. The role of Veillonellaceace on aph-
thous ulcers was controversial [21, 23], and our results
couldn’t suggest a significant correlation between this
group of bacteria with RAS.
The work we performed suggested that the
colonization of E. coli or Alloprevotella, more likely the
former, may be the cause of RAS. However, it needs to
be pointed out that this suggestion is not conclusive, as
finding an association is not equivalent to finding the
causality. We cannot rule out the possibility that RAS
leads to increased abundance of E. coli and Alloprevo-
tella, in contrary to our hypothesis that increased abun-
dance of E. coli and/or Alloprevotella leads to RAS.
Furthermore, consideration on other possible complica-
tions influencing oral environment and bacterial com-
munity structures, such as other underlying conditions
and drug use, was not included in this investigation,
which was due to the assumption that they are not
major drivers of the oral microbiomes and these effects
may be minimized by stringent statistics. A much larger
surveillance is still needed to identify detailed factors in-
fluencing oral microbiomes. Nevertheless, the findings of
this work, in particularly the coincidence that E. coli
colonization and RAS occurence are both common,
points to a high possibility to the etiology of RAS. Fur-
ther in-depth pathological work is needed to confirm
this possibility. These findings have the potentials to
guide the discovery of new cures for RAS, which may in-
clude targeting oral E. coli colonization and removing it
using antibiotics.
Conclusions
In conclusion, we compared the microbiomes of normal
oral mucosa and aphthous ulcers of 24 subjects by high
Fig. 4 LEfSe analysis of investigated bacterial communities. a the LDA scores of significant biomarkers; b The Cladogram of significant biomarkers.
The diameters of each circle are proportional to its relative abundance
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throughput sequencing, and identified bacterial groups
that represent both oral mucosa and aphthous ulcers. A
novel proposal was made that E. coli or Alloprevotella,
more likely the former, may be the cause of RAS. This
work can provide a new road for finding the etiology of
RAS, which will help searching for effective cures to this
common disease. Limitations of this work still exist in-
cluding the inability to find out whether the change of
oral microbiomes is the reason or the result of RAS, and
the limit on sample size which prevents us from carrying
out analysis on more factors that potentially affect oral
microbiome. Further larger surveillance and more
in vivo experimentation is warranted to address these
limitations in the future.
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